Bowel (colorectal) cancer, Pancreatic cancer, Secondary cancers
Open
Phase 1/2
This trial is looking at MK-2870 by itself or in combination with other drugs for some cancers of the .
It is open for people with the following cancers that have spread to another part of the body or cannot be removed by surgery:
bowel cancer
pancreatic cancer
bile duct cancer. The team have enough people in this group. It is now closed to recruitment.
gallbladder cancer. The team have enough people in this group. It is now closed to recruitment.
Bile duct cancer and gallbladder cancer are also called biliary tree cancers.
Recruitment start: 16 August 2024
Recruitment end: 24 July 2025
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Marco Gerlinger
Merck Sharp & Dohme
Last reviewed: 20 May 2025
CRUK internal database number: 19935